Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Unclassified sarcomas: a study to improve classification in a cohort of Golden Retriever dogs.

Boerkamp KM, Hellmén E, Willén H, Grinwis GC, Teske E, Rutteman GR.

J Vet Diagn Invest. 2016 Nov;28(6):623-631. Epub 2016 Oct 3.

PMID:
27698172
2.

Serum Galectin-3 Levels in Dogs with Metastatic and Non-metastatic Mammary Tumors.

Ribeiro C, Santos MS, DE Matos AJ, Barros R, Gärtner F, Rutteman GR, DE Oliveira JT.

In Vivo. 2016 Jan-Feb;30(1):13-6.

PMID:
26709123
3.

Genome-Wide Association Study of Golden Retrievers Identifies Germ-Line Risk Factors Predisposing to Mast Cell Tumours.

Arendt ML, Melin M, Tonomura N, Koltookian M, Courtay-Cahen C, Flindall N, Bass J, Boerkamp K, Megquir K, Youell L, Murphy S, McCarthy C, London C, Rutteman GR, Starkey M, Lindblad-Toh K.

PLoS Genet. 2015 Nov 20;11(11):e1005647. doi: 10.1371/journal.pgen.1005647. eCollection 2015 Nov.

4.

Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.

de Oliveira JT, Ribeiro C, Barros R, Gomes C, de Matos AJ, Reis CA, Rutteman GR, Gärtner F.

PLoS One. 2015 Jul 29;10(7):e0134458. doi: 10.1371/journal.pone.0134458. eCollection 2015.

5.

Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma.

Campos M, Ducatelle R, Rutteman G, Kooistra HS, Duchateau L, de Rooster H, Peremans K, Daminet S.

J Vet Intern Med. 2014 Nov-Dec;28(6):1805-13. doi: 10.1111/jvim.12436. Epub 2014 Sep 24.

6.

Upregulation of the PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinoma.

Campos M, Kool MM, Daminet S, Ducatelle R, Rutteman G, Kooistra HS, Galac S, Mol JA.

J Vet Intern Med. 2014 Nov-Dec;28(6):1814-23. doi: 10.1111/jvim.12435. Epub 2014 Sep 17.

7.

The two main forms of histiocytic sarcoma in the predisposed Flatcoated retriever dog display variation in gene expression.

Boerkamp KM, van Steenbeek FG, Penning LC, Groot Koerkamp MJ, van Leenen D, Vos-Loohuis M, Grinwis GC, Rutteman GR.

PLoS One. 2014 Jun 2;9(6):e98258. doi: 10.1371/journal.pone.0098258. eCollection 2014.

8.

Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.

DE Oliveira JT, DE Matos AJ, Barros R, Ribeiro C, Chen A, Hespanhol V, Rutteman GR, Gärtner F.

Anticancer Res. 2014 May;34(5):2211-21.

PMID:
24778023
9.

Immunohistochemical expression of potential therapeutic targets in canine thyroid carcinoma.

Campos M, Ducatelle R, Kooistra HS, Rutteman G, Duchateau L, Polis I, Daminet S.

J Vet Intern Med. 2014 Mar-Apr;28(2):564-70. doi: 10.1111/jvim.12330. Epub 2014 Feb 24.

10.

Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever population.

Boerkamp KM, Teske E, Boon LR, Grinwis GC, van den Bossche L, Rutteman GR.

BMC Vet Res. 2014 Jan 31;10:34. doi: 10.1186/1746-6148-10-34.

11.

Causes of death and the impact of histiocytic sarcoma on the life expectancy of the Dutch population of Bernese mountain dogs and Flat-coated retrievers.

Erich SA, Rutteman GR, Teske E.

Vet J. 2013 Dec;198(3):678-83. doi: 10.1016/j.tvjl.2013.09.062. Epub 2013 Oct 1.

PMID:
24231621
12.

Gene expression profiling of histiocytic sarcomas in a canine model: the predisposed flatcoated retriever dog.

Boerkamp KM, van der Kooij M, van Steenbeek FG, van Wolferen ME, Groot Koerkamp MJ, van Leenen D, Grinwis GC, Penning LC, Wiemer EA, Rutteman GR.

PLoS One. 2013 Aug 1;8(8):e71094. doi: 10.1371/journal.pone.0071094. Print 2013.

13.

Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results.

Zandvliet M, Rutteman GR, Teske E.

Vet J. 2013 Sep;197(3):656-61. doi: 10.1016/j.tvjl.2013.04.022. Epub 2013 Jun 6. Erratum in: Vet J. 2015 Apr;204(1):130.

PMID:
23746872
14.

Safety and efficacy field study of artesunate for dogs with non-resectable tumours.

Rutteman GR, Erich SA, Mol JA, Spee B, Grinwis GC, Fleckenstein L, London CA, Efferth T.

Anticancer Res. 2013 May;33(5):1819-27.

PMID:
23645726
15.

Progesterone receptor isoforms in the mammary gland of cats and dogs.

Gracanin A, de Gier J, Zegers K, Bominaar M, Rutteman GR, Schaefers-Okkens AC, Kooistra HS, Mol JA.

Reprod Domest Anim. 2012 Dec;47 Suppl 6:313-7. doi: 10.1111/rda.12045.

PMID:
23279527
16.

The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer.

Shearin AL, Hedan B, Cadieu E, Erich SA, Schmidt EV, Faden DL, Cullen J, Abadie J, Kwon EM, Gröne A, Devauchelle P, Rimbault M, Karyadi DM, Lynch M, Galibert F, Breen M, Rutteman GR, André C, Parker HG, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1019-27. doi: 10.1158/1055-9965.EPI-12-0190-T. Epub 2012 May 23.

17.

Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.

Tavares C, de Oliveira JT, Lopes C, Carvalheira J, Matos AJ, Rutteman G, Reis CA, Gärtner F.

J Comp Pathol. 2012 Nov;147(4):410-8. doi: 10.1016/j.jcpa.2012.03.007. Epub 2012 May 15.

PMID:
22595635
18.

Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma.

Teske E, van Lankveld AJ, Rutteman GR.

Vet Comp Oncol. 2014 Mar;12(1):37-46. doi: 10.1111/j.1476-5829.2012.00329.x. Epub 2012 Apr 10.

PMID:
22489828
19.

Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.

Matos AJ, Baptista CS, Gärtner MF, Rutteman GR.

Vet J. 2012 Jul;193(1):24-31. doi: 10.1016/j.tvjl.2011.12.019. Epub 2012 Jan 31. Review.

PMID:
22296767
20.

Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability.

Boerkamp KM, Rutteman GR, Kik MJ, Kirpensteijn J, Schulze C, Grinwis GC.

Cancers (Basel). 2012 Dec 3;4(4):1300-17. doi: 10.3390/cancers4041300.

Supplemental Content

Loading ...
Support Center